Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis

Journal of Immunology

Volumn 162, Issue 9, 1999, Pages 5511-5518

  Keane, Michael P ^a   Belperio, John A ^a   Moore, Thomas A ^a   Moore, Bethany B ^a   Arenberg, Douglas A ^a   Smith, Robert E ^b   Burdick, Marie D ^a   Kunkel, Steven L ^b   Strieter, Robert M ^a,b  

^a Division of Pulmonary and Critical Care Medicine   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; BLEOMYCIN SULFATE; HYDROXYPROLINE; MACROPHAGE INFLAMMATORY PROTEIN 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOASSAY; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; LUNG FIBROSIS; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BLEOMYCIN; CELL DIFFERENTIATION; CELL MOVEMENT; CHEMOKINES, CXC; COLLAGEN; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION; IMMUNE SERA; IMMUNIZATION, PASSIVE; IMMUNOHISTOCHEMISTRY; LUNG; MICE; MICE, INBRED CBA; MONOKINES; NEOVASCULARIZATION, PATHOLOGIC; NEUTROPHILS; PULMONARY FIBROSIS; RATS; RATS, LONG-EVANS;

EID: 0033137106     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Coultas, D. B., R. E. Zumwalt, W. C. Black, and R. E. Sobonya. 1994. The epidemiology of interstitial lung diseases. Am. J. Respir. Crit. Care Med. 150: 967.
2. du Bois, R. M. 1997. Diffuse lung disease: a view for the future. Sarcoidosis Vasc. Diffuse Lung Dis. 14:23.
3. Turner-Warwick, M. 1963. Precapillary systemic-pulmonary anastomoses. Thorax 18:225.
4. Peao, M. N. D., A. P. Aguas, C. M. DeSa, and N. R. Grande. 1994. Neoformation of blood vessels in association with rat lung fibrosis induced by bleomycin. Anat. Rec. 238:57.
5. Strieter, R. M., P. J. Polverini, S. L. Kunkel, D. A. Arenberg, M. D. Burdick, J. Kasper, J. Dzuiba, J. Van Damme, A. Walz, D. Marriott, et al. 1995. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J. Biol. Chem. 270:27348.
6. Koch, A. E., P. J. Polverini, S. L. Kunkel, L. A. Harlow, L. A. DiPietro, V. M. Elner, S. G. Elner, and R. M. Strieter. 1992. Interleukin-8 (IL-8) as a macrophage-derived mediator of angiogenesis. Science 258:1798.
7. Hu, D. E., Y. Hori, and T. P. D. Fan. 1993. Interleukin-8 stimulates angiogenesis in rats. Inflammation 17:135.
8. Strieter, R. M., S. L. Kunkel, V. M. Elner, C. L. Martonyl, A. E. Koch, P. J. Polverini, and S. G. Elner. 1992. Interleukin-8: a corneal factor that induces neovascularization. Am. J. Pathol. 141:1279.
9. Keane, M. P., D. A. Arenberg, J. P. Lynch, R. I. Whyte, M. D. Iannettoni, M. D. Burdick, C. A. Wilke, S. B. Morris, M. C. Glass, B. DiGiovine, et al. 1997. The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. J. Immunol. 159:1437.
10. Arenberg, D. A., S. L. Kunkel, P. J. Polverini, M. Glass, M. D. Burdick, and R. M. Strieter. 1996. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J. Clin. Invest. 97:2792.
11. Arenberg, D. A., S. L. Kunkel, P. J. Polverini, S. B. Morris, M. D. Burdick, M. Glass, D. T. Taub, M. D. Iannetoni, R. I. Whyte, and R. M. Strieter. 1996. Interferon-γ-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases. J. Exp. Med. 184:981.
12. Smith, R. E., R. M. Strieter, S. H. Phan, N. W. Lukacs, G. B. Huffnagle, C. A. Wilke, M. D. Burdick, P. Lincoln, H. Evanoff, and S. L. Kunkel. 1994. Production and function of murine macrophage inflammatory protein-1α in bleomycin-induced lung injury. J. Immunol. 153:4704.
13. Smith, D. R., P. J. Polverini, S. L. Kunkel, M. B. Orringer, R. I. Whyte, M. D. Burdick, C. A. Wilke, and R. M. Strieter. 1994. IL-8 mediated angiogenesis in human bronchogenic carcinoma. J. Exp. Med. 179:1409.
14. + T cells in the protective inflammatory response to a pulmonary cryptococcal infection. J. Leukocyte Biol. 55:35.
15. Colletti, L. M., S. L. Kunkel, A. Walz, M. D. Burdick, R. G. Kunkel, C. A. Wilke, and R. M. Strieter. 1995. Chemokine expression during hepatic ischemia/reperfusion-induced lung injury in the rat: the role of epithelial neutrophil activating protein. J. Clin. Invest. 95:134.
16. Henke, C., V. Fiegel, M. Peterson, M. Wick, D. Knighton, J McCarthy, and P. Bitterman. 1991. Identification and partial characterization of angiogenesis bioactivity in the lower respiratory tract after acute lung injury. J. Clin. Invest. 88:1386.
17. Marinelli, W. A., C. A. Henke, K. R. Harmon, M. I. Hertz, and P. B. Bitterman. 1990. Mechanisms of alveolar fibrosis after acute lung injury. Clin. Chest. Med. 11:657.
18. Adamson, I. Y., and D. H. Bowden. 1974. The pathogenesis of bleomycin-induced pulmonary fibrosis in mice. Am. J. Pathol. 77:185.
19. Chandler, D. B. 1990. Possible mechanisms of bleomycin-induced fibrosis. Clin. Chest Med. 11:21.
20. Bowden, D. H. 1984. Unraveling pulmonary fibrosis: the bleomycin model. Lab. Invest. 50:487.
21. Bedrossian, C. M. W., S. D. Grennberg, D. H. Yawn, and R. M. O'Neil. 1977. Experimentally induced bleomycin sulfate pulmonary toxicity. Arch. Pathol. Lab. Med. 101:248.
22. Aso, Y., and Y. Yoneda. 1976. Morphological and biochemical study of pulmonary changes induced by bleomycin in mice. Lab. Invest. 35:558.
23. Schrier, D. J., R. G. Kunkel, and S. H. Phan. 1983. The role of strain variation in murine bleomycin-induced pulmonary fibrosis. Am. Rev. Respir. Dis. 127:63.
24. Smith, R. E., R. M. Strieter, S. H. Phan, and S. L. Kunkel. 1996. CC chemokines: novel mediators of the profibrotic inflammatory response to bleomycin challenge. Am. J. Respir. Cell Mol. Biol. 15:693.
25. Chandler, D. B., D. M. Hyde, and S. N. Gin. 1983. Morphometric estimates of infiltrative cellular changes during the development of bleomycin-induced pulmonary fibrosis in hamsters. Am. J. Pathol. 112:170.
26. Piguet, P., C. Vesin, G. Grau, and R. C. Thompson. 1993. Interleukin 1 receptor antagonist (IL-1ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica. Cytokine 5:57.
27. Webb, L. M. C., M. U. Ehrengruber, I. Clark-Lewis, M. Baggiolini, and A. Rot. 1993. Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. Proc. Natl. Acad. Sci. USA 90:7158.
28. Thrall, R. H., S. H. Phan, J. R. McCormick, and P. A. Ward. 1981. The development of bleomycin-induced pulmonary fibrosis in neutrophil-depleted and complement-depleted rats. Am. J. Pathol. 105:76.
29. Koch, A. E., P. J. Polverini, and S. J. Leibovich. 1986. Stimulation of neovascularization by human rheumatoid synovial tissue macrophages. Arthritis Rheum. 29:471.
30. Nickoloff, B. J., R. S. Mitra, J. Varani, V. M. Dixit, and P. J. Polverini. 1994. Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratin-ocytes. Am. J. Pathol. 144:820.
31. Koch, A. E., S. L. Kunkel, J. L. Burrows, H. L. Evanoff, G. K. Haines, R. M. Pope, and R. M. Strieter. 1991. The synovial tissue macrophage as a source of the chemotactic cytokine interleukin-8. J. Immunol. 147:2187.
32. Piguet, P. F., C. Vesin, G. E. Grau, and R. C. Thompson. 1993. Interleukin 1 receptor antagonist (IL-1ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica. Cytokine 5:57.
33. Piguet, P. F., C. Vesin, and F. Thomas. 1995. Bombesin down modulates pulmonary fibrosis elicited in mice by bleomycin. Exp. Lung Res. 21:227.
34. Gurujeyalakshmi, G., and S. N. Giri. 1995. Molecular mechanisms of antifibrotic effect of interferon γ in bleomycin-mouse model of lung fibrosis: downregulation of TGF-β and procollagen I and III gene expression. Exp. Lung Res. 21:791.
35. Raines, E. W., D. F. Bowen-Pope, and R. Ross. 1990. Platelet-derived growth factor. In Handbook of Experimental Pharmacology, Vol. 95: Peptide Growth Factors and Their Receptors. M. B. Sporn and A. B. Roberts, eds. Springer-Verlag, Heidelberg, pp. 173-262.
36. Remmers, E. F., H. Sano, and R. L. Wilder. 1991. Platelet-derived growth factors and heparin-binding (fibroblast) growth factors in the synovial tissue pathology of rheumatoid arthritis. Semin. Arthritis Rheum. 21:191.
37. Postlethwaite, A. E., J. Keski-Oja, H. L. Moses, and A. H. Kang. 1987. Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor β. J. Exp. Med. 165:251.
38. Leof, E. B., J. A. Proper, A. S. Goustin, G. D. Shipley, P. E. Dicorleto, and H. L. Moses. 1986. Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor β: a proposed model for indirect mitogenesis involving autocrine activity. Proc. Natl. Acad. Sci. USA 83:2453.
39. Clark, R. A. 1985. Cutaneous tissue repair: basic biologic considerations. I. Am. Acad. Dermatol. 13:701.
40. Clark, R. A. 1993. Basics of cutaneous wound repair. J. Dermatol. Surg. Oncol. 19:693.
41. Clark, R. A. 1993. Regulation of fibroplasia in cutaneous wound repair. Am. J. Med. Sci. 306:42.